Work

PRMT5 is a therapeutic vulnerability in cutaneous T-cell lymphoma

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-1529

Authors: Nicole Peterman, Pushpa Lata, Christoph Weigel, Sydney Leon, Ian Hout, Wing Chan, Ronny Schmidt, Ha Tran, Youssef Youssef, Peggy Scherle, Neha Bhagwat, John Reneau, Catherine Chung, Jonathan Brammer, Ryan Wilcox, Lapo Alinari, Robert Baiocchi, Walter Hanel

Institutions: The Ohio State University Wexner Medical Center, The University of Texas MD Anderson Cancer Center, Prelude Therapeutics Incorporated (United States), University of Michigan

Language: English

Topic: Cancer-related gene regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7108609825

Cites:

Cited by:

Related to: